capitalbrief4h
Dow ends week at record high after tame inflation report
The blue-chip Dow Jones Industrial Average closed at a record high on Friday as a subdued US inflation report lifted ...
This FDA-approved drug promises a new way to treat schizophrenia
Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...
The Times of Israel11h
Quiet experts in shaping this world
True expertise is built slowly, through years of dedicated study, self-questioning, and experimentation. The quiet experts – ...
stockhead15h
Market Highlights: All eyes on another ASX record, and why investors could pile on stocks before year-end
ASX could hit record high despite mixed bag on Wall Street. US stocks expected to outperform bonds as Fed cuts rates.
eNCA16hOpinion
New drug for schizophrenics has experts excited
WASHINGTON - Experts expressed enthusiasm after US health regulators approved the first new form of treatment for ...
The Pharma Letter16h
The week in pharma: action, reaction and insight – week to September 27
Significant regulatory news last week included the US Food and Drug Administration (FDA) granting approval for Zevra ...
devdiscourse22h
A Snapshot of Current Health Developments
Bristol Myers gains FDA approval for a new schizophrenia drug. HHS declares a health emergency in Georgia due to Hurricane ...
Health and Me on MSN23h
Breakthrough in Schizophrenia Treatment: FDA Approves Cobenfy
New drug offers hope for patients with Schizophrenia that has long eluded effective treatment. Read on to know more.